Thyroid Eye Disease
📧 Sign up to get email alerts when something new happens for Thyroid Eye Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-11-24FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental application for Tepezza (teprotumumab) from Horizon Therapeutics USA, Inc., potentially expanding its indication…
-
FDA approval · 2025-09-09FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental application for TEPEZZA (teprotumumab) submitted by Horizon Therapeutics USA, Inc.
-
FDA approval · 2025-08-26FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental application for TEPEZZA (teprotumumab) from Horizon Therapeutics USA, expanding its approved indication for thyr…
-
EMA approval · 2025-04-25First treatment against severe thyroid eye disease
The European Medicines Agency approved Tepezza (teprotumumab) as the first treatment for severe thyroid eye disease, offering significant sy…
-
FDA approval · 2023-04-13FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA overview of a supplemental application for TEPEZZA (teprotumumab) by Horizon Therapeutics USA, Inc.; the submission status is AP.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-12-06FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
The FDA approved a supplemental application for TEPEZZA (teprotumumab) submitted by Horizon Therapeutics USA, Inc.
-
FDA approval · 2020-01-21FDA Approved: TEPEZZA — Original Application (Horizon Therapeutics USA, Inc.)
The FDA approved TEPEZZA (teprotumumab) from Horizon Therapeutics USA, Inc. under an original biologics license application. This marks the …